Table of Contents Table of Contents
Previous Page  995 / 1851 Next Page
Information
Show Menu
Previous Page 995 / 1851 Next Page
Page Background

Cisplatin/Pemetrexed:

a valuable option for Stage IIIB/IV NON-squamous NSCLC

Scagliotti GV. et al. JCO 2008;26

FAVORS Pemetrexed

OS

OS

FAVORS Gemcitabine